Community Healthcare Trust (CHCT) 10-Q 5 May 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2020	Apr. 30, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	001-37401
Entity Registrant Name	Community Healthcare Trust Inc
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	46-5212033
Entity Address, Address Line One	3326 Aspen Grove Drive
Entity Address, Address Line Two	Suite 150
Entity Address, City or Town	Franklin
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37067
City Area Code	615
Local Phone Number	771-3052
Title of 12(b) Security	Common stock, $0.01 par value per share
Trading Symbol	CHCT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		22,163,856
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Real estate properties
Land and land improvements	$ 74,680	$ 68,129
Buildings, improvements, and lease intangibles	566,954	534,503
Personal property	222	220
Total real estate properties	641,856	602,852
Less accumulated depreciation	(83,582)	(77,523)
Total real estate properties, net	558,274	525,329
Cash and cash equivalents	3,326	1,730
Restricted cash	282	293
Other assets, net	34,872	35,179
Total assets	596,754	562,531
Liabilities
Debt, net	203,276	194,243
Accounts payable and accrued liabilities	5,297	3,606
Other liabilities	20,406	11,271
Total liabilities	228,979	209,120
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 22,125,269 and 21,410,578 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	221	214
Additional paid-in capital	475,824	447,916
Cumulative net income	21,654	17,554
Accumulated other comprehensive loss	(13,426)	(4,808)
Cumulative dividends	(116,498)	(107,465)
Total stockholders’ equity	367,775	353,411
Total liabilities and stockholders' equity	$ 596,754	$ 562,531

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred Stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized (in shares)	450,000,000	450,000,000
Common Stock, shares issued (in shares)	22,125,269	21,410,578
Common Stock, shares outstanding (in shares)	22,125,269	21,410,578

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
REVENUES
Rental income	$ 17,428	$ 12,898
Other operating interest	508	543
Revenues	17,936	13,441
EXPENSES
Property operating	3,343	3,075
General and administrative	2,192	1,785
Depreciation and amortization	6,059	5,246
Expenses	11,594	10,106
INCOME FROM OPERATIONS	6,342	3,335
Interest expense	(2,249)	(2,054)
Interest and other income, net	7	169
NET INCOME	$ 4,100	$ 1,450
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.18	$ 0.06
Net income per common share – Diluted (in dollars per share)	$ 0.18	$ 0.06
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	20,734,618	17,954,670
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	20,734,618	17,954,670

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 4,100	$ 1,450
Other comprehensive (loss) income:
Decrease in fair value of cash flow hedges	(8,875)	(1,213)
Reclassification for amounts recognized as interest expense	257	(62)
Total other comprehensive loss	(8,618)	(1,275)
COMPREHENSIVE (LOSS) INCOME	$ (4,518)	$ 175

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Cumulative Net Income	Accumulated Other Comprehensive (Loss) Income	Cumulative Dividends
Beginning Balance at Dec. 31, 2018	$ 271,659	$ 186	$ 337,180	$ 9,178	$ 633	$ (75,518)
Beginning Balance (in shares) at Dec. 31, 2018		18,634,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		143,600
Issuance of common stock, net of issuance costs	4,624	$ 2	4,622
Stock-based compensation (in shares)		84,690
Stock-based compensation	853	$ 1	852
Unrecognized gain (loss) on cash flow hedges	(1,213)				(1,213)
Reclassification adj for gain (losses) included in net income (interest expense)	(62)				(62)
Net income	1,450			1,450
Dividends to common stockholders	(7,628)					(7,628)
Ending Balance (in shares) at Mar. 31, 2019		18,862,792
Ending Balance at Mar. 31, 2019	269,683	$ 189	342,654	10,628	(642)	(83,146)
Beginning Balance at Dec. 31, 2018	$ 271,659	$ 186	337,180	9,178	633	(75,518)
Beginning Balance (in shares) at Dec. 31, 2018		18,634,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	2,554,247
Ending Balance (in shares) at Dec. 31, 2019		21,410,578
Ending Balance at Dec. 31, 2019	$ 353,411	$ 214	447,916	17,554	(4,808)	(107,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	610,786	610,786
Issuance of common stock, net of issuance costs	$ 26,902	$ 6	26,896
Stock-based compensation (in shares)		103,905
Stock-based compensation	1,013	$ 1	1,012
Unrecognized gain (loss) on cash flow hedges	(8,875)				(8,875)
Reclassification adj for gain (losses) included in net income (interest expense)	257				257
Net income	4,100			4,100
Dividends to common stockholders	(9,033)					(9,033)
Ending Balance (in shares) at Mar. 31, 2020		22,125,269
Ending Balance at Mar. 31, 2020	$ 367,775	$ 221	$ 475,824	$ 21,654	$ (13,426)	$ (116,498)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cumulative Dividends
Dividends to common stockholders, per share (in dollars per share)	$ 0.4175	$ 0.4075

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
OPERATING ACTIVITIES
Net income	$ 4,100	$ 1,450
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	6,059	5,246
Other amortization	127	175
Stock-based compensation	1,013	853
Straight-line rent receivable	(878)	(336)
Deferred income tax expense	0	17
Changes in operating assets and liabilities:
Other assets	(235)	(194)
Accounts payable and accrued liabilities	396	155
Other liabilities	(329)	(36)
Net cash provided by operating activities	10,253	7,330
INVESTING ACTIVITIES
Acquisitions of real estate	(36,384)	(32,743)
Acquisition of note receivable	(1,750)	0
Proceeds from the repayment of notes receivable	3,300	31
Capital expenditures on existing real estate properties	(673)	(622)
Net cash used in investing activities	(35,507)	(33,334)
FINANCING ACTIVITIES
Net borrowings (repayments) on revolving credit facility	9,000
Net borrowings (repayments) on revolving credit facility		(43,000)
Term loan borrowings	0	75,000
Mortgage note repayments	(27)	(27)
Dividends paid	(9,033)	(7,628)
Proceeds from issuance of common stock	26,928	4,724
Equity issuance costs	(29)	(100)
Debt issuance costs	0	(1,323)
Net cash provided by financing activities	26,839	27,646
Increase in cash and cash equivalents and restricted cash	1,585	1,642
Cash and cash equivalents and restricted cash, beginning of period	2,023	2,392
Cash and cash equivalents and restricted cash, end of period	3,608	4,034
Supplemental Cash Flow Information:
Interest paid	1,876	1,783
Invoices accrued for construction, tenant improvement and other capitalized costs	1,165	81
Reclassification between accounts and notes receivable	0	40
Reclassification of registration statement costs incurred in prior year to equity issuance costs	32	100
Leasing commission accrued	125
Decrease in fair value of cash flow hedges	(8,875)	(1,213)
Income taxes paid	$ 2	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. As of March 31, 2020 , the Company had investments of approximately $641.9 million in 124 real estate properties, located in 33 states, totaling approximately 2.7 million square feet in the aggregate. Any references to square footage or occupancy percentages, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm's review. Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2020 . All material intercompany accounts and transactions have been eliminated. A novel strain of coronavirus (SARS-CoV-2) was first identified in late 2019, and subsequently declared a global pandemic by the World Health Organization. The Company considered the impact of SARS-CoV-2 on the assumptions and estimates used for the three months ended March 31, 2020. The full extent of the future impacts of SARS-CoV-2 on the Company's operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amount approximates fair value due to the short term maturity of these investments. The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of March 31, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 3,326 $ 3,868 Restricted cash 282 166 Cash, cash equivalents and restricted cash $ 3,608 $ 4,034 Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES" Act) was enacted into law and was immediately effective. The CARES Act includes new provisions that allow for the carryback of net operating losses, provides relief of the taxable income limitation for the net operating losses and increases the business interest limitation from 30% to 50%. The Company is continuing to evaluate the impact the CARES Act may have on the Company's income taxes. New Accounting Pronouncements Recently Adopted Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies are required to use a new current expected credit loss ("CECL") model that generally results in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies are required to measure credit losses in a manner similar to prior guidance, except that the losses are recognized as allowances rather than as reductions in the amortized cost of the securities. In November 2018, the FASB amended the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. Companies have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies must apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company adopted ASU No. 2016-13 on January 1, 2020. The Company did not record an adjustment upon adoption as the impact was determined to be immaterial. However, this standard could impact the Company's financial statements and results of operations in future periods. Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform

Real Estate Investments

Real Estate Investments	3 Months Ended
	Mar. 31, 2020
Real Estate [Abstract]
Real Estate Investments	Real Estate Investments At March 31, 2020 , the Company had investments of approximately $641.9 million in 124 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,665 $ 29,410 $ — $ 34,075 $ 6,145 Ohio 6 3,665 26,646 — 30,311 6,923 Texas 6 5,425 21,582 — 27,007 5,299 Illinois 3 1,983 15,049 — 17,032 3,774 Kansas 3 2,468 17,298 — 19,766 4,744 Iowa 1 2,241 9,342 — 11,583 3,085 Other states 21 9,400 55,445 — 64,845 7,442 45 29,847 174,772 — 204,619 37,412 Physician clinics: Kansas 2 610 6,920 — 7,530 1,895 Illinois 6 2,888 9,728 — 12,616 1,145 Florida 5 506 10,322 — 10,828 1,304 Other states 9 2,903 21,755 — 24,658 4,529 22 6,907 48,725 — 55,632 8,873 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 1,777 Michigan 2 637 8,842 — 9,479 2,812 Illinois 2 2,355 8,255 — 10,610 2,183 Florida 1 271 7,070 — 7,341 1,276 Arizona 2 576 5,389 — 5,965 1,944 Other states 7 2,144 17,936 — 20,080 4,987 15 7,666 68,845 — 76,511 14,979 Specialty centers: Illinois 3 3,489 24,740 — 28,229 3,716 Other states 25 6,866 45,012 — 51,878 9,499 28 10,355 69,752 — 80,107 13,215 Behavioral facilities: Massachusetts 1 3,835 23,303 — 27,138 520 West Virginia 1 2,138 22,897 — 25,035 1,462 Illinois 1 1,300 18,803 — 20,103 1,803 Washington 1 2,725 25,064 — 27,789 363 Other states 5 2,546 18,894 — 21,440 1,343 9 12,544 108,961 — 121,505 5,491 Inpatient rehabilitation facilities: Arkansas 1 2,014 17,028 — 19,042 5 Texas 3 4,824 61,751 — 66,575 1,273 4 6,838 78,779 — 85,617 1,278 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 1,911 1 523 14,405 — 14,928 1,911 Corporate property — — 2,715 222 2,937 423 Total real estate investments 124 $ 74,680 $ 566,954 $ 222 $ 641,856 $ 83,582

Real Estate Leases

Real Estate Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Real Estate Leases	Real Estate Leases The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2035 . The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease. Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2020 , are as follows (in thousands): 2020 (nine months ending December 31) $ 43,558 2021 55,465 2022 51,975 2023 47,086 2024 43,905 2025 and thereafter 273,367 $ 515,356 Straight-line rental income Rental income is recognized as earned over the life of the lease agreement on a straight-line basis when collection of rental payments over the term of the lease is probable. Straight-line rent included in rental income was approximately $0.9 million and $0.3 million , respectively, for the three months ended March 31, 2020 and 2019 . Deferred revenue Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities on the Condensed Consolidated Balance Sheet, was approximately $ 2.1 million and $2.0 million , respectively, at March 31, 2020 and December 31, 2019

Real Estate Acquisitions

Real Estate Acquisitions	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Real Estate Acquisitions	Real Estate Acquisitions 2020 Real Estate Acquisitions During the first quarter of 2020 , the Company acquired six real estate properties as detailed in the table below. Upon acquisition, the properties were 98.2% leased in the aggregate with lease expirations through 2035 . Amounts reflected in revenues and net income for these properties for the three months ended March 31, 2020 were approximately $0.3 million and $0.1 million , respectively, and transaction costs totaling approximately $0.2 million were capitalized relating to these property acquisitions. Location Property Type (1) Date Acquired Purchase Price Cash Consideration Real Estate Other (2) Square Footage (000's) (000's) (000's) (000's) San Antonio, TX MOB 01/27/20 $ 4,003 $ 4,022 $ 4,036 $ (14 ) 13,500 San Antonio, TX MOB 01/27/20 1,931 1,955 1,961 (6 ) 6,500 Decatur, AL MOB 02/18/20 5,784 5,792 5,777 15 35,943 Ramona, CA SC 03/13/20 4,100 4,124 4,143 (19 ) 11,300 Cuero, TX SC 03/18/20 2,153 2,174 2,207 (33 ) 15,515 Rogers, AR IRF 03/27/20 19,000 18,317 19,042 (725 ) 38,817 $ 36,971 $ 36,384 $ 37,166 $ (782 ) 121,575 (1) MOB - Medical Office Building; SC - Specialty Center; IRF - Inpatient Rehabilitation Facility (2) Includes, but is not limited to, above- and below-market lease intangibles, liabilities assumed, and security deposits. The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the three months ended March 31, 2020 . Relative Fair Value Estimated Useful Life (in thousands) (in years) Land and land improvements $ 6,501 12.3 Building and building improvements 28,559 41.2 Intangibles: At-market lease intangibles 2,106 4.0 Above-market lease intangibles 122 7.1 Below-market lease intangibles (96 ) 3.6 Total intangibles 2,132 Accounts payable, accrued liabilities and other liabilities assumed (533 ) Prorated rent, interest and operating expense reimbursement amounts collected (275 ) Total cash consideration $ 36,384

Debt, net

Debt, net	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt, net	Debt, net The table below details the Company's debt as of March 31, 2020 and December 31, 2019 . Balance as of (Dollars in thousands) March 31, 2020 December 31, 2019 Maturity Dates Revolving Credit Facility $ 24,000 $ 15,000 3/23 A-1 Term Loan, net 49,852 49,833 3/22 A-2 Term Loan, net 49,788 49,775 3/24 A-3 Term Loan, net 74,456 74,433 3/26 Mortgage Note Payable 5,180 5,202 5/24 $ 203,276 $ 194,243 The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, the lenders from time to time party thereto, and Truist Bank (formerly SunTrust Bank), as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility, as amended, provides for a $150.0 million Revolving Credit Facility and $175.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $525.0 million including the ability to add and fund additional term loans. The Revolving Credit Facility matures on March 29, 2023 and includes one 12 -month option to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five -year term loan facility in the aggregate principal amount of $50.0 million (the "A-1 Term Loan"), which matures on March 29, 2022 , a seven -year term loan facility in the aggregate principal amount of $50.0 million (the "A-2 Term Loan"), which matures on March 29, 2024 , and a seven -year, $75.0 million A-3 Term Loan, which matures on March 29, 2026 . Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 1.90% or (ii) a base rate plus 0.25% to 0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. The Company had $24.0 million outstanding under the Revolving Credit Facility with a 2.50% weighted average interest rate at March 31, 2020, and a borrowing capacity remaining of approximately $126.0 million at March 31, 2020 . Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 2.30% or (ii) a base rate plus 0.25% to 1.30% , in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company has entered into interest rate swaps to fix the interest rates on the Term Loans. See Note 6 for more details on the interest rate swaps. At March 31, 2020 , the Company had drawn the full $175.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.569% . The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. The Company was in compliance with its financial covenants under its Credit Facility as of March 31, 2020 .

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract. As of March 31, 2020 , the Company had seven outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $175.0 million . The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at March 31, 2020 December 31, 2019 Balance Sheet Classification March 31, 2020 December 31, 2019 Balance Sheet Classification Interest rate swaps $ — $ — Other assets $ 13,426 $ 4,808 Other Liabilities The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive (loss) income ("AOCI") and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $3.4 million will be reclassified from other comprehensive (loss) income ("OCI") as an increase to interest expense. The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2020 and 2019 . Three Months Ended March 31, (Dollars in thousands) 2020 2019 Amount of unrealized loss recognized in OCI on derivative $ (8,875 ) $ (1,213 ) Amount of loss (gain) reclassified from accumulated OCI into interest expense $ 257 $ (62 ) Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,249 $ 2,054 Credit-risk-related Contingent Feature s As of March 31, 2020 , the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $14.0 million . As of March 31, 2020 , the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $14.0 million at March 31, 2020 .

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2020 and for the year ended December 31, 2019 : Three Months Ended Year Ended December 31, 2019 Balance, beginning of period 21,410,578 18,634,502 Issuance of common stock 610,786 2,554,247 Restricted stock-based awards 103,905 221,829 Balance, end of period 22,125,269 21,410,578 ATM Program On November 5, 2019, the Company entered into an Amended and Restated Sales Agency Agreement ("Amended and Restated Sales Agreement") for its at-the-market offering program ("ATM Program") with Sandler O’Neill & Partners, L.P., Evercore Group L.L.C., SunTrust Robinson Humphrey, Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC, as sales agents (collectively, the “Agents”), under which the Company may issue and sell shares of its common stock, having an aggregate gross sales price of up to $360.0 million . The shares of common stock may be sold from time to time through or to one or more of the Agents, as may be determined by the Company in its sole discretion, subject to the terms and conditions of the agreement and applicable law. The Company's activity under the ATM Program for the three months ended March 31, 2020 is detailed in the table below. As of March 31, 2020 , the Company had approximately $274.3 million remaining that may be issued under the ATM Program. Three Months Ended Shares issued 610,786 Net proceeds received (in millions) $ 26.9 Average gross sales price per share $ 44.99 The Company sold an additional 38,587 shares for net proceeds of approximately $1.4 million under the ATM Program at the end of March 2020 that were not settled and issued until April 2020.

Net Income Per Common Share

Net Income Per Common Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Income Per Common Share	Net Income Per Common Share The following table sets forth the computation of basic and diluted net income per common share for the three months ended March 31, 2020 and 2019 , respectively. Three Months Ended (Dollars in thousands, except per share data) 2020 2019 Net income $ 4,100 $ 1,450 Participating securities' share in earnings (424 ) (324 ) Net income, less participating securities' share in earnings $ 3,676 $ 1,126 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 21,732,430 18,735,673 Unvested restricted shares (997,812 ) (781,003 ) Weighted average Common Shares outstanding–Basic 20,734,618 17,954,670 Dilutive potential common shares — — Weighted average Common Shares outstanding –Diluted 20,734,618 17,954,670 Basic Net Income per Common Share $ 0.18 $ 0.06 Diluted Net Income per Common Share $ 0.18 $ 0.06

Incentive Plan

Incentive Plan	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Incentive Plan	Incentive Plan A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three months ended March 31, 2020 and 2019 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods. Three Months Ended March 31, (Dollars in thousands) 2020 2019 Stock-based awards, beginning of period 909,892 709,487 Stock in lieu of compensation 50,245 42,525 Stock awards 53,660 42,165 Total stock granted 103,905 84,690 Stock-based awards, end of period 1,013,797 794,177 Amortization expense $ 1,019 $ 853

Other Assets, net

Other Assets, net	3 Months Ended
	Mar. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets, net	Other Assets, net Other assets, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 are detailed in the table below. Balance as of (Dollars in thousands) March 31, 2020 December 31, 2019 Notes receivable $ 21,950 $ 23,500 Lease and interest receivables 3,252 3,021 Straight-line rent receivables 6,146 5,267 Prepaid assets 484 488 Deferred financing costs, net 639 693 Leasing commissions, net 959 875 Deferred tax asset 595 595 Above-market intangible assets, net 257 144 Right-of-use leased asset 139 139 Other 451 457 $ 34,872 $ 35,179 The Company's notes receivable at March 31, 2020 included: • two loans with a borrower totaling $21.4 million which are secured by all assets and ownership interests in the operations of seven long-term acute care hospitals and one inpatient rehabilitation hospital owned by the borrower. The notes mature on December 31, 2025 and bear interest at 9% per annum. • a $2.5 million loan, acquired by the Company for $1.75 million , to help facilitate the bankruptcy filing of a borrower. The Company subsequently received a payment of $1.2 million on the note and had a carrying balance of $0.6 million at March 31, 2020 which is secured by all assets and personal property of the borrower. The note is due on demand and bears interest at 10% per annum. The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at March 31, 2020 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 21.4 $ 21.4 Notes receivable $ 0.6 $ 0.6

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value. Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value. Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy. Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates. Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy. Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy. The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at March 31, 2020 and December 31, 2019 , using level 2 inputs. March 31, 2020 December 31, 2019 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 21,950 $ 21,670 $ 23,500 $ 23,399 Interest rate swap liability $ 13,426 $ 13,426 $ 4,808 $ 4,808 Mortgage note payable $ 5,261 $ 5,589 $ 5,288 $ 5,351

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend Declared On May 4, 2020 , the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.42 per share. The dividend is payable on May 29, 2020 to stockholders of record on May 15, 2020 . Subsequent Acquisitions Subsequent to March 31, 2020 , the Company acquired one property with approximately 10,000 square feet for a purchase price of approximately $3.9 million and expects to fund an additional $1.5 million in tenant improvements. The property is 100% leased with the lease expiring in 2035 . COVID-19 pandemic Many healthcare providers have been impacted by the COVID-19 pandemic. Some of them are not seeing patients, others have seen a reduced number of elective procedures and/or patient visits, while others have experienced limited impact, or have even seen improved cash flows from either increases in census or from government funding. The Company has entered into, or is negotiating, deferral agreements with several of its tenants. Based upon need and request the Company has been providing these tenants, generally, with two to three months of base rent deferral (the tenant continues to pay operating expenses). Pursuant to these agreements the tenants are, generally, required to repay the deferred amounts with funds received from business interruption insurance and/or the Payroll Protection Program of the CARES Act - with any remaining balance paid in equal monthly installments during the third and fourth quarters of 2020.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2020 . All material intercompany accounts and transactions have been eliminated.
Use of Estimates in the Condensed Consolidated Financial Statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.
Cash and Cash Equivalents	Cash, Cash Equivalents and Restricted Cash
Restricted Cash	Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amount approximates fair value due to the short term maturity of these investments.
Income Taxes	Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES" Act) was enacted into law and was immediately effective. The CARES Act includes new provisions that allow for the carryback of net operating losses, provides relief of the taxable income limitation for the net operating losses and increases the business interest limitation from 30% to 50%. The Company is continuing to evaluate the impact the CARES Act may have on the Company's income taxes.
New Accounting Pronouncements	New Accounting Pronouncements Recently Adopted Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies are required to use a new current expected credit loss ("CECL") model that generally results in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies are required to measure credit losses in a manner similar to prior guidance, except that the losses are recognized as allowances rather than as reductions in the amortized cost of the securities. In November 2018, the FASB amended the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. Companies have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies must apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company adopted ASU No. 2016-13 on January 1, 2020. The Company did not record an adjustment upon adoption as the impact was determined to be immaterial. However, this standard could impact the Company's financial statements and results of operations in future periods. Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of March 31, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 3,326 $ 3,868 Restricted cash 282 166 Cash, cash equivalents and restricted cash $ 3,608 $ 4,034
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of March 31, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 3,326 $ 3,868 Restricted cash 282 166 Cash, cash equivalents and restricted cash $ 3,608 $ 4,034

Real Estate Investments (Tables

Real Estate Investments (Tables)	3 Months Ended
	Mar. 31, 2020
Real Estate [Abstract]
Schedule of real estate property investments	At March 31, 2020 , the Company had investments of approximately $641.9 million in 124 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,665 $ 29,410 $ — $ 34,075 $ 6,145 Ohio 6 3,665 26,646 — 30,311 6,923 Texas 6 5,425 21,582 — 27,007 5,299 Illinois 3 1,983 15,049 — 17,032 3,774 Kansas 3 2,468 17,298 — 19,766 4,744 Iowa 1 2,241 9,342 — 11,583 3,085 Other states 21 9,400 55,445 — 64,845 7,442 45 29,847 174,772 — 204,619 37,412 Physician clinics: Kansas 2 610 6,920 — 7,530 1,895 Illinois 6 2,888 9,728 — 12,616 1,145 Florida 5 506 10,322 — 10,828 1,304 Other states 9 2,903 21,755 — 24,658 4,529 22 6,907 48,725 — 55,632 8,873 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 1,777 Michigan 2 637 8,842 — 9,479 2,812 Illinois 2 2,355 8,255 — 10,610 2,183 Florida 1 271 7,070 — 7,341 1,276 Arizona 2 576 5,389 — 5,965 1,944 Other states 7 2,144 17,936 — 20,080 4,987 15 7,666 68,845 — 76,511 14,979 Specialty centers: Illinois 3 3,489 24,740 — 28,229 3,716 Other states 25 6,866 45,012 — 51,878 9,499 28 10,355 69,752 — 80,107 13,215 Behavioral facilities: Massachusetts 1 3,835 23,303 — 27,138 520 West Virginia 1 2,138 22,897 — 25,035 1,462 Illinois 1 1,300 18,803 — 20,103 1,803 Washington 1 2,725 25,064 — 27,789 363 Other states 5 2,546 18,894 — 21,440 1,343 9 12,544 108,961 — 121,505 5,491 Inpatient rehabilitation facilities: Arkansas 1 2,014 17,028 — 19,042 5 Texas 3 4,824 61,751 — 66,575 1,273 4 6,838 78,779 — 85,617 1,278 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 1,911 1 523 14,405 — 14,928 1,911 Corporate property — — 2,715 222 2,937 423 Total real estate investments 124 $ 74,680 $ 566,954 $ 222 $ 641,856 $ 83,582

Real Estate Leases (Tables)

Real Estate Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Schedule of future minimum lease payments for operating leases	Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2020 , are as follows (in thousands): 2020 (nine months ending December 31) $ 43,558 2021 55,465 2022 51,975 2023 47,086 2024 43,905 2025 and thereafter 273,367 $ 515,356

Real Estate Acquisitions (Table

Real Estate Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Schedule of acquisitions	Location Property Type (1) Date Acquired Purchase Price Cash Consideration Real Estate Other (2) Square Footage (000's) (000's) (000's) (000's) San Antonio, TX MOB 01/27/20 $ 4,003 $ 4,022 $ 4,036 $ (14 ) 13,500 San Antonio, TX MOB 01/27/20 1,931 1,955 1,961 (6 ) 6,500 Decatur, AL MOB 02/18/20 5,784 5,792 5,777 15 35,943 Ramona, CA SC 03/13/20 4,100 4,124 4,143 (19 ) 11,300 Cuero, TX SC 03/18/20 2,153 2,174 2,207 (33 ) 15,515 Rogers, AR IRF 03/27/20 19,000 18,317 19,042 (725 ) 38,817 $ 36,971 $ 36,384 $ 37,166 $ (782 ) 121,575 (1) MOB - Medical Office Building; SC - Specialty Center; IRF - Inpatient Rehabilitation Facility (2) Includes, but is not limited to, above- and below-market lease intangibles, liabilities assumed, and security deposits.
Schedule of assets acquired and liabilities assumed	The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the three months ended March 31, 2020 . Relative Fair Value Estimated Useful Life (in thousands) (in years) Land and land improvements $ 6,501 12.3 Building and building improvements 28,559 41.2 Intangibles: At-market lease intangibles 2,106 4.0 Above-market lease intangibles 122 7.1 Below-market lease intangibles (96 ) 3.6 Total intangibles 2,132 Accounts payable, accrued liabilities and other liabilities assumed (533 ) Prorated rent, interest and operating expense reimbursement amounts collected (275 ) Total cash consideration $ 36,384

Debt, net (Tables)

Debt, net (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of debt	The table below details the Company's debt as of March 31, 2020 and December 31, 2019 . Balance as of (Dollars in thousands) March 31, 2020 December 31, 2019 Maturity Dates Revolving Credit Facility $ 24,000 $ 15,000 3/23 A-1 Term Loan, net 49,852 49,833 3/22 A-2 Term Loan, net 49,788 49,775 3/24 A-3 Term Loan, net 74,456 74,433 3/26 Mortgage Note Payable 5,180 5,202 5/24 $ 203,276 $ 194,243

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of derivative instruments on balance sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at March 31, 2020 December 31, 2019 Balance Sheet Classification March 31, 2020 December 31, 2019 Balance Sheet Classification Interest rate swaps $ — $ — Other assets $ 13,426 $ 4,808 Other Liabilities
Schedule of derivative gain (loss)	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2020 and 2019 . Three Months Ended March 31, (Dollars in thousands) 2020 2019 Amount of unrealized loss recognized in OCI on derivative $ (8,875 ) $ (1,213 ) Amount of loss (gain) reclassified from accumulated OCI into interest expense $ 257 $ (62 ) Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,249 $ 2,054

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of reconciliation of common stock	The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2020 and for the year ended December 31, 2019 : Three Months Ended Year Ended December 31, 2019 Balance, beginning of period 21,410,578 18,634,502 Issuance of common stock 610,786 2,554,247 Restricted stock-based awards 103,905 221,829 Balance, end of period 22,125,269 21,410,578
Schedule of ATM Program	As of March 31, 2020 , the Company had approximately $274.3 million remaining that may be issued under the ATM Program. Three Months Ended Shares issued 610,786 Net proceeds received (in millions) $ 26.9 Average gross sales price per share $ 44.99

Net Income Per Common Share (Ta

Net Income Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the computation of basic and diluted net income per common share for the three months ended March 31, 2020 and 2019 , respectively. Three Months Ended (Dollars in thousands, except per share data) 2020 2019 Net income $ 4,100 $ 1,450 Participating securities' share in earnings (424 ) (324 ) Net income, less participating securities' share in earnings $ 3,676 $ 1,126 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 21,732,430 18,735,673 Unvested restricted shares (997,812 ) (781,003 ) Weighted average Common Shares outstanding–Basic 20,734,618 17,954,670 Dilutive potential common shares — — Weighted average Common Shares outstanding –Diluted 20,734,618 17,954,670 Basic Net Income per Common Share $ 0.18 $ 0.06 Diluted Net Income per Common Share $ 0.18 $ 0.06

Incentive Plan (Tables)

Incentive Plan (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Summary of nonvested restricted stock activity	A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three months ended March 31, 2020 and 2019 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods. Three Months Ended March 31, (Dollars in thousands) 2020 2019 Stock-based awards, beginning of period 909,892 709,487 Stock in lieu of compensation 50,245 42,525 Stock awards 53,660 42,165 Total stock granted 103,905 84,690 Stock-based awards, end of period 1,013,797 794,177 Amortization expense $ 1,019 $ 853

Other Assets, net (Tables)

Other Assets, net (Tables)	3 Months Ended
	Mar. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Other assets, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 are detailed in the table below. Balance as of (Dollars in thousands) March 31, 2020 December 31, 2019 Notes receivable $ 21,950 $ 23,500 Lease and interest receivables 3,252 3,021 Straight-line rent receivables 6,146 5,267 Prepaid assets 484 488 Deferred financing costs, net 639 693 Leasing commissions, net 959 875 Deferred tax asset 595 595 Above-market intangible assets, net 257 144 Right-of-use leased asset 139 139 Other 451 457 $ 34,872 $ 35,179
Schedule of VIEs	The VIEs that we have identified at March 31, 2020 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 21.4 $ 21.4 Notes receivable $ 0.6 $ 0.6

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at March 31, 2020 and December 31, 2019 , using level 2 inputs. March 31, 2020 December 31, 2019 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 21,950 $ 21,670 $ 23,500 $ 23,399 Interest rate swap liability $ 13,426 $ 13,426 $ 4,808 $ 4,808 Mortgage note payable $ 5,261 $ 5,589 $ 5,288 $ 5,351

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands, ft² in Millions	Mar. 31, 2020USD ($)ft²statereal_estate_property	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Accounting Policies [Abstract]
Value of real estate property investments and mortgages	$ 641,900
Number of real estate properties | real_estate_property	124
Number of states | state	33
Area of real estate property (in square feet) | ft²	2.7
Cash and cash equivalents	$ 3,326	$ 1,730	$ 3,868
Restricted cash	282	293	166
Cash, cash equivalents and restricted cash	$ 3,608	$ 2,023	$ 4,034	$ 2,392

Real Estate Investments - Addit

Real Estate Investments - Additional Information (Details) $ in Millions	Mar. 31, 2020USD ($)real_estate_property
Real Estate [Abstract]
Value of real estate property investments and mortgages | $	$ 641.9
Number of real estate properties | real_estate_property	124

Real Estate Investments - Sched

Real Estate Investments - Schedule of Real Estate Property Investments (Details) $ in Thousands	Mar. 31, 2020USD ($)real_estate_property	Dec. 31, 2019USD ($)
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	124
Land and Land Improvements	$ 74,680	$ 68,129
Buildings, Improvements, and Lease Intangibles	566,954	534,503
Personal Property	222	220
Total real estate properties	641,856	602,852
Accumulated Depreciation	$ 83,582	$ 77,523
Medical office
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	45
Land and Land Improvements	$ 29,847
Buildings, Improvements, and Lease Intangibles	174,772
Personal Property	0
Total real estate properties	204,619
Accumulated Depreciation	$ 37,412
Medical office | Florida
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 4,665
Buildings, Improvements, and Lease Intangibles	29,410
Personal Property	0
Total real estate properties	34,075
Accumulated Depreciation	$ 6,145
Medical office | Illinois
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 1,983
Buildings, Improvements, and Lease Intangibles	15,049
Personal Property	0
Total real estate properties	17,032
Accumulated Depreciation	$ 3,774
Medical office | Iowa
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,241
Buildings, Improvements, and Lease Intangibles	9,342
Personal Property	0
Total real estate properties	11,583
Accumulated Depreciation	$ 3,085
Medical office | Kansas
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 2,468
Buildings, Improvements, and Lease Intangibles	17,298
Personal Property	0
Total real estate properties	19,766
Accumulated Depreciation	$ 4,744
Medical office | Ohio
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 3,665
Buildings, Improvements, and Lease Intangibles	26,646
Personal Property	0
Total real estate properties	30,311
Accumulated Depreciation	$ 6,923
Medical office | Other States
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	21
Land and Land Improvements	$ 9,400
Buildings, Improvements, and Lease Intangibles	55,445
Personal Property	0
Total real estate properties	64,845
Accumulated Depreciation	$ 7,442
Medical office | Texas
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 5,425
Buildings, Improvements, and Lease Intangibles	21,582
Personal Property	0
Total real estate properties	27,007
Accumulated Depreciation	$ 5,299
Physician clinics
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	22
Land and Land Improvements	$ 6,907
Buildings, Improvements, and Lease Intangibles	48,725
Personal Property	0
Total real estate properties	55,632
Accumulated Depreciation	$ 8,873
Physician clinics | Florida
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 506
Buildings, Improvements, and Lease Intangibles	10,322
Personal Property	0
Total real estate properties	10,828
Accumulated Depreciation	$ 1,304
Physician clinics | Illinois
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 2,888
Buildings, Improvements, and Lease Intangibles	9,728
Personal Property	0
Total real estate properties	12,616
Accumulated Depreciation	$ 1,145
Physician clinics | Kansas
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 610
Buildings, Improvements, and Lease Intangibles	6,920
Personal Property	0
Total real estate properties	7,530
Accumulated Depreciation	$ 1,895
Physician clinics | Other States
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	9
Land and Land Improvements	$ 2,903
Buildings, Improvements, and Lease Intangibles	21,755
Personal Property	0
Total real estate properties	24,658
Accumulated Depreciation	$ 4,529
Surgical Centers and Hospitals
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	15
Land and Land Improvements	$ 7,666
Buildings, Improvements, and Lease Intangibles	68,845
Personal Property	0
Total real estate properties	76,511
Accumulated Depreciation	$ 14,979
Surgical Centers and Hospitals | Arizona
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 576
Buildings, Improvements, and Lease Intangibles	5,389
Personal Property	0
Total real estate properties	5,965
Accumulated Depreciation	$ 1,944
Surgical Centers and Hospitals | Florida
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 271
Buildings, Improvements, and Lease Intangibles	7,070
Personal Property	0
Total real estate properties	7,341
Accumulated Depreciation	$ 1,276
Surgical Centers and Hospitals | Illinois
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 2,355
Buildings, Improvements, and Lease Intangibles	8,255
Personal Property	0
Total real estate properties	10,610
Accumulated Depreciation	$ 2,183
Surgical Centers and Hospitals | Louisiana
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,683
Buildings, Improvements, and Lease Intangibles	21,353
Personal Property	0
Total real estate properties	23,036
Accumulated Depreciation	$ 1,777
Surgical Centers and Hospitals | Michigan
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 637
Buildings, Improvements, and Lease Intangibles	8,842
Personal Property	0
Total real estate properties	9,479
Accumulated Depreciation	$ 2,812
Surgical Centers and Hospitals | Other States
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	7
Land and Land Improvements	$ 2,144
Buildings, Improvements, and Lease Intangibles	17,936
Personal Property	0
Total real estate properties	20,080
Accumulated Depreciation	$ 4,987
Specialty Centers
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	28
Land and Land Improvements	$ 10,355
Buildings, Improvements, and Lease Intangibles	69,752
Personal Property	0
Total real estate properties	80,107
Accumulated Depreciation	$ 13,215
Specialty Centers | Illinois
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,489
Buildings, Improvements, and Lease Intangibles	24,740
Personal Property	0
Total real estate properties	28,229
Accumulated Depreciation	$ 3,716
Specialty Centers | Other States
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	25
Land and Land Improvements	$ 6,866
Buildings, Improvements, and Lease Intangibles	45,012
Personal Property	0
Total real estate properties	51,878
Accumulated Depreciation	$ 9,499
Behavioral facilities
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	9
Land and Land Improvements	$ 12,544
Buildings, Improvements, and Lease Intangibles	108,961
Personal Property	0
Total real estate properties	121,505
Accumulated Depreciation	$ 5,491
Behavioral facilities | Illinois
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,300
Buildings, Improvements, and Lease Intangibles	18,803
Personal Property	0
Total real estate properties	20,103
Accumulated Depreciation	$ 1,803
Behavioral facilities | Massachusetts
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 3,835
Buildings, Improvements, and Lease Intangibles	23,303
Personal Property	0
Total real estate properties	27,138
Accumulated Depreciation	$ 520
Behavioral facilities | Other States
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 2,546
Buildings, Improvements, and Lease Intangibles	18,894
Personal Property	0
Total real estate properties	21,440
Accumulated Depreciation	$ 1,343
Behavioral facilities | Washington
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,725
Buildings, Improvements, and Lease Intangibles	25,064
Personal Property	0
Total real estate properties	27,789
Accumulated Depreciation	$ 363
Behavioral facilities | West Virginia
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,138
Buildings, Improvements, and Lease Intangibles	22,897
Personal Property	0
Total real estate properties	25,035
Accumulated Depreciation	$ 1,462
Inpatient Rehabilitation Facilities
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 6,838
Buildings, Improvements, and Lease Intangibles	78,779
Personal Property	0
Total real estate properties	85,617
Accumulated Depreciation	$ 1,278
Inpatient Rehabilitation Facilities | Arkansas
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,014
Buildings, Improvements, and Lease Intangibles	17,028
Personal Property	0
Total real estate properties	19,042
Accumulated Depreciation	$ 5
Inpatient Rehabilitation Facilities | Texas
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 4,824
Buildings, Improvements, and Lease Intangibles	61,751
Personal Property	0
Total real estate properties	66,575
Accumulated Depreciation	$ 1,273
Long-Term Acute Care Hospitals
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Personal Property	0
Total real estate properties	14,928
Accumulated Depreciation	$ 1,911
Long-Term Acute Care Hospitals | Indiana
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Personal Property	0
Total real estate properties	14,928
Accumulated Depreciation	$ 1,911
Corporate property
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	0
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	2,715
Personal Property	222
Total real estate properties	2,937
Accumulated Depreciation	$ 423

Real Estate Leases (Details)

Real Estate Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Real Estate [Line Items]
2020 (nine months ending December 31)	$ 43,558
2021	55,465
2022	51,975
2023	47,086
2024	43,905
2025 and thereafter	273,367
Total	515,356
Straight Line rent	878	$ 336
Other Liabilities
Real Estate [Line Items]
Deferred revenue	$ 2,100		$ 2,000

Real Estate Acquisitions - Real

Real Estate Acquisitions - Real Estate Acquisitions (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)real_estate_property
Business Acquisition [Line Items]
Number of real estate properties acquired | real_estate_property	6
Percentage of properties that were leased at acquisition	98.20%
Acquisition Of Properties During 1st Quarter 2020
Business Acquisition [Line Items]
Pro forma information, revenue of acquiree since acquisition date, actual	$ 0.3
Pro forma information, earnings or loss of acquiree since acquisition date, actual	0.1
Transaction costs	$ 0.2

Real Estate Acquisitions - Re_2

Real Estate Acquisitions - Real Estate Acquisitions - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)ft²
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Square Footage (in square feet) | ft²	2,700,000
Acquisition Of Properties During 1st Quarter 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 36,971
Cash Consideration	36,384
Real Estate	37,166
Other	$ (782)
Square Footage (in square feet) | ft²	121,575
Acquisition Of Properties During 1st Quarter 2020 | San Antonio, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 4,003
Cash Consideration	4,022
Real Estate	4,036
Other	$ (14)
Square Footage (in square feet) | ft²	13,500
Acquisition Of Properties During 1st Quarter 2020 | San Antonio, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 1,931
Cash Consideration	1,955
Real Estate	1,961
Other	$ (6)
Square Footage (in square feet) | ft²	6,500
Acquisition Of Properties During 1st Quarter 2020 | Decatur, AL
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 5,784
Cash Consideration	5,792
Real Estate	5,777
Other	$ 15
Square Footage (in square feet) | ft²	35,943
Acquisition Of Properties During 1st Quarter 2020 | Ramona, CA
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 4,100
Cash Consideration	4,124
Real Estate	4,143
Other	$ (19)
Square Footage (in square feet) | ft²	11,300
Acquisition Of Properties During 1st Quarter 2020 | Cuero, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,153
Cash Consideration	2,174
Real Estate	2,207
Other	$ (33)
Square Footage (in square feet) | ft²	15,515
Acquisition Of Properties During 1st Quarter 2020 | Rogers, AR
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 19,000
Cash Consideration	18,317
Real Estate	19,042
Other	$ (725)
Square Footage (in square feet) | ft²	38,817

Real Estate Acquisitions - Asse

Real Estate Acquisitions - Assets Acquired and Liabilities Assumed (Details) - Series of Individually Immaterial Asset Acquisitions $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Business Acquisition [Line Items]
Land and land improvements	$ 6,501
Building and building improvements	28,559
Below-market lease intangibles	$ (96)
Below market lease useful life (in years)	3 years 7 months 6 days
Total intangibles	$ 2,132
Accounts payable, accrued liabilities and other liabilities assumed	(533)
Prorated rent, interest and operating expense reimbursement amounts collected	(275)
Total cash consideration	36,384
At-market lease intangibles
Business Acquisition [Line Items]
Lease intangibles	$ 2,106
Intangibles useful life (in years)	4 years
Above-market lease intangibles
Business Acquisition [Line Items]
Lease intangibles	$ 122
Intangibles useful life (in years)	7 years 1 month 6 days
Land and Land Improvements
Business Acquisition [Line Items]
Useful life (in years)	12 years 3 months 18 days
Building and Building Improvements
Business Acquisition [Line Items]
Useful life (in years)	41 years 2 months 12 days

Debt, net - Schedule of Debt (D

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt, net	$ 203,276	$ 194,243
Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	175,000
Mortgage Note Payable
Debt Instrument [Line Items]
Debt, net	5,180	5,202
Revolving Credit Facility | Line of Credit | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	24,000	15,000
A-1 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	49,852	49,833
A-2 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	49,788	49,775
A-3 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	$ 74,456	$ 74,433

Debt, net - Narrative (Details)

Debt, net - Narrative (Details)	Mar. 29, 2019USD ($)option	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Line of Credit Facility [Line Items]
Amount outstanding		$ 203,276,000	$ 194,243,000
Third Amended And Restated Credit Facility | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 175,000,000
Unused borrowing commitment fee percentage	0.35%
Amount outstanding		$ 175,000,000
Weighted average interest rate percentage		4.569%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	2.30%
Third Amended And Restated Credit Facility | Base Rate | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility | Base Rate | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.30%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000
Number of options to extend | option	1
Length of extension	12 months
Amount outstanding		$ 24,000,000	15,000,000
Remaining borrowing capacity		$ 126,000,000
Weighted average interest rate percentage		2.50%
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.90%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.90%
Third Amended And Restated Credit Facility | Credit Facility, Accordion Feature
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 525,000,000
Third Amended And Restated Credit Facility | A-1 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	5 years
Amount outstanding		$ 49,852,000	49,833,000
Third Amended And Restated Credit Facility | A-2 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	7 years
Amount outstanding		49,788,000	49,775,000
Third Amended And Restated Credit Facility | A-3 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 75,000,000
Debt term	7 years
Amount outstanding		$ 74,456,000	$ 74,433,000
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.25%
Percentage of borrowing capacity outstanding	33.30%
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.35%
Percentage of borrowing capacity outstanding	33.30%

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details)	3 Months Ended
	Mar. 31, 2020USD ($)derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 3,400,000
Cash Flow Hedging | Interest Rate Contract
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	7
Notional amount	$ 175,000,000
Termination value	$ 14,000,000

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value Balance Sheet (Details) - Cash Flow Hedging - Interest Rate Swap - Designated as Hedging Instrument - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Derivative liability	$ 14,000
Other Assets
Derivatives, Fair Value [Line Items]
Derivative asset	0	$ 0
Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	$ 13,426	$ 4,808

Derivative Financial Instrume_5

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract - Cash Flow Hedging - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized loss recognized in OCI on derivative	$ (8,875)	$ (1,213)
Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of loss (gain) reclassified from accumulated OCI into interest expense	257	(62)
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 2,249	$ 2,054

Stockholders' Equity - Reconcil

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	21,410,578	18,634,502
Issuance of common stock (in shares)	610,786	2,554,247
Restricted stock-based awards (in shares)	103,905	221,829
Balance, end of period (in shares)	22,125,269	21,410,578

Stockholders' Equity - Equity O

Stockholders' Equity - Equity Offering (Details) - At The Market Offering Program - Common Stock - USD ($) $ / shares in Units, $ in Millions	Mar. 31, 2020	Nov. 05, 2019	Mar. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Value of shares authorized		$ 360
Remaining availability under ATM program	$ 274.3		$ 274.3
Shares issued (in shares)	38,587		610,786
Net proceeds received	$ 1.4		$ 26.9
Average gross sales price per share (in dollars per share)			$ 44.99

Net Income Per Common Share (De

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Net income	$ 4,100	$ 1,450
Participating securities' share in earnings	(424)	(324)
Net income, less participating securities' share in earnings	$ 3,676	$ 1,126
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	21,732,430	18,735,673
Unvested restricted shares (in shares)	(997,812)	(781,003)
Weighted average Common Shares outstanding–Basic (in shares)	20,734,618	17,954,670
Dilutive potential common share (in shares)	0	0
Weighted average Common Shares outstanding –Diluted (in shares)	20,734,618	17,954,670
Basic Net Income per Common Share (in dollars per share)	$ 0.18	$ 0.06
Diluted Net Income per Common Share (in dollars per share)	$ 0.18	$ 0.06

Incentive Plan - Restricted Sto

Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restricted Common Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	909,892	709,487
Granted (in shares)	103,905	84,690
Stock-based awards, end of period (in shares)	1,013,797	794,177
Amortization expense	$ 1,019	$ 853
Restricted Common Stock, Stock in Lieu of Compensation
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	50,245	42,525
Restricted Common Stock, Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	53,660	42,165

Other Assets, net - Other Asset

Other Assets, net - Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 21,950	$ 23,500
Lease and interest receivables	3,252	3,021
Straight-line rent receivables	6,146	5,267
Prepaid assets	484	488
Deferred financing costs, net	639	693
Leasing commissions, net	959	875
Deferred tax asset	595	595
Above-market intangible assets, net	257	144
Right-of-use leased asset	139	139
Other	451	457
Other assets, net	$ 34,872	$ 35,179

Other Assets, net - Narrative (

Other Assets, net - Narrative (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)loanhospital	Dec. 31, 2019USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 21,950	$ 23,500
Long-Term Acute Care Hospitals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Inpatient Rehabilitation Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1
Note Receivable 1 | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | loan	2
Notes receivable	$ 21,400
Note receivable interest rate	9.00%
Note Receivable 2 | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 600	2,500
Payment to acquire finance receivable		$ 1,750
Payment received	$ 1,200
Note receivable interest rate	10.00%

Other Assets, net - VIEs (Detai

Other Assets, net - VIEs (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Variable Interest Entity [Line Items]
Carrying Amount	$ 21,950	$ 23,500
Notes Receivable | Variable Interest Entity One
Variable Interest Entity [Line Items]
Carrying Amount	21,400
Maximum Exposure to Loss	21,400
Notes Receivable | Variable Interest Entity Two
Variable Interest Entity [Line Items]
Carrying Amount	600
Maximum Exposure to Loss	$ 600

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	$ 21,950	$ 23,500
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	21,950	23,500
Mortgage note payable	5,261	5,288
Carrying Value | Interest Rate Swap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap liability	13,426	4,808
Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	21,670	23,399
Mortgage note payable	5,589	5,351
Fair Value | Interest Rate Swap | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap liability	$ 13,426	$ 4,808

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, ft² in Thousands, $ in Millions	May 04, 2020$ / shares	May 05, 2020USD ($)ft²real_estate_property	Mar. 31, 2020ft²real_estate_property
Subsequent Event [Line Items]
Number of real estate properties acquired | real_estate_property			6
Area of real estate property (in square feet) | ft²			2,700
Percentage of properties that were leased at acquisition			98.20%
Subsequent Event
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares	$ 0.42
Number of real estate properties acquired | real_estate_property		1
Area of real estate property (in square feet) | ft²		10
Purchase price | $		$ 3.9
Tenant improvements | $		$ 1.5
Percentage of properties that were leased at acquisition		100.00%